Tirabrutinib
(Redirected from Velexbru)
Tirabrutinib is a Bruton tyrosine kinase (BTK) inhibitor used in the treatment of certain types of cancer. It is particularly effective in treating B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Tirabrutinib works by inhibiting the BTK enzyme, which plays a crucial role in the signaling pathways that promote the survival and proliferation of B-cells.
Mechanism of Action[edit | edit source]
Tirabrutinib binds irreversibly to the BTK enzyme, thereby inhibiting its activity. BTK is a key component of the B-cell receptor (BCR) signaling pathway, which is essential for the growth and survival of malignant B-cells. By blocking BTK, tirabrutinib disrupts these signaling pathways, leading to the apoptosis (programmed cell death) of cancerous B-cells.
Clinical Uses[edit | edit source]
Tirabrutinib is primarily used in the treatment of:
- Chronic lymphocytic leukemia (CLL)
- Mantle cell lymphoma (MCL)
- Other B-cell malignancies
Side Effects[edit | edit source]
Common side effects of tirabrutinib include:
Serious side effects may include:
- Infections
- Cytopenias (reduction in the number of blood cells)
- Cardiac arrhythmias
Development and Approval[edit | edit source]
Tirabrutinib was developed by Ono Pharmaceutical and has undergone various clinical trials to establish its efficacy and safety. It has been approved for use in several countries for the treatment of specific B-cell malignancies.
See Also[edit | edit source]
- Bruton tyrosine kinase
- B-cell receptor
- Chronic lymphocytic leukemia
- Mantle cell lymphoma
- B-cell malignancies
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
